Government Policy

The California Co-Pay Conundrum

January 2, 2018

TrialCard Addresses AB 265 On October 9, 2017, California Governor Jerry Brown signed AB 265 into law. This landmark piece of legislation modified the California Health and Safety Code to prohibit the “offering” of any discount, product voucher, or other out-of-pocket cost reduction tool by drug manufacturers when there is an FDA-approved therapeutic equivalent. As […]

Symcel secures €3.6 million Horizon 2020 Phase II grant for clinical validation of customized antimicrobial susceptibility testing

November 27, 2017

Symcel: 21 November 2017: Symcel, the company behind the revolutionary cell-based assay tool for real-time cell metabolism measurements, calScreener™, has secured €3.572 million Horizon 2020 funding to support the company’s evaluation of improved combination testing of antibiotics against extensively drug-resistant bacteria in sepsis patients. The project runs over 28 months with a consortium of internationally recognized […]

US Dept. of Veterans Affairs Renews and Expands Cancer Testing Contract with Personal Genome Diagnostics

November 13, 2017

–-PGDx’s Pan-Cancer Profiling Panels with MSI Testing for Immuno-Oncology Applications Are Now Available Nationwide to Cancer Patients Treated at the VA–                                                                                                   –PGDx’s CancerSELECTTM 125 Offers Comprehensive Tissue-Based Tumor Profiling and Its PlasmaSELECTTM 64 Is First Liquid Biopsy Assay Available to Patients at VA Facilities— BALTIMORE, MD –Personal Genome Diagnostics Inc. (PGDx) today announced the renewal […]

New Peer-Reviewed Study Finds Illegal Online Pharmacies are Using Twitter to Illegally Sell Percocet®, Fentanyl, Vicodin®, Oxycotin®, and Other Highly Addictive Opiods To U.S. Consumers

October 26, 2017

SAN DIEGO, CA (October 26, 2017) – Results from a new peer-reviewed study to be published in the November issue of American Journal of Public Health (AJPH) found illegal online pharmacies are using Twitter to market and sell Percocet®, Vicodin®, Oxycontin®, hydrocodone, fentanyl and oxycodone and other highly addictive and often deadly controlled substances to U.S. consumers, […]

India’s generics exports expanding 22% per year

October 24, 2017

Country accounts for over 20% of global production with $20 billion exports forecast by 2020 24th October 2017, Frankfurt: The India Brand Equity foundation (IBEF) and the Pharmaceuticals Export Promotion Council (PHARMEXCIL) provide an update on the country’s generics market as the world’s pharma industry meets for its annual exposition at CPhI Worldview in Frankfurt. Data confirms that […]

Science Exchange to Host Webinar on How to Prepare for EU General Data Protection Regulation (GDPR)

October 3, 2017

PALO ALTO, CA, SEPTEMBER 27, 2017 – Science Exchange, the world’s leading and most secure platform for outsourced research and development (R&D), announced today that it will host a webinar titled, “Are You Ready? Preparing for EU Data Protection Regulation.” At this free, online event on Tuesday, October 3, at 11:00 am ET, Science Exchange […]

APPCON India – ASIAN Pharma Packaging Conference

August 21, 2017

APPCON India – ASIAN Pharma Packaging Conference Location: Mumbai-India Dates: 2nd & 3rdNovember 2017 For Agenda/Event Brochure, Information & Registration, Contact: Priyesh Waghmare E: | T: +91 (0)20.6527.2803 Quote discount code: PPCi1MP20 to claim for 20% discount expiring 7th September 2017 & PPCi1MP15 to claim for 15% discount expiring 19th October 2017 The objective of the conference is to secure and optimize packaging by navigating […]

CR Expo China 2017 Poised to Boost Rise of Assistive Device Industry

August 21, 2017

The press conference for Care & Rehabilitation Expo China 2017 was held at China Disabled Persons’ Federation, on August 14th, 2017. Present at the conference are leaders including HU Xiangyang, Director of Rehabilitation Department of China Disabled Persons’ Federation, LI Xi, Director of China Assistive Devices and Technology Centre for Persons with Disabilities, OU Ling, […]

China FDA, US FDA and industry leaders collaborated with great success during Marketing Authorization Holder system summit

July 18, 2017

Discussions at the MAH symposium showed a positive outlook with the pilot program and calls for the marketing authorization system to be adopted nationwide. STA Pharmaceutical Co., Ltd. (STA)  – a WuXi AppTec subsidiary and a leading open-access capability and technology platform for small molecule pharmaceutical development and manufacturing – co-organized a summit along with […]

US immigration order strikes against biotech

February 9, 2017

We the undersigned, founders and leaders of biotech companies, write to express our deep concern and opposition to the executive order signed by President Donald Trump on January 27, 2017, barring the entry of citizens from seven countries into the United States1.   The United States is the world’s greatest developer of medicines and new […]

Biotech execs blast Trump’s travel ban

February 9, 2017

Dive Brief: As a federal appeals court deliberates over President Trump’s travel ban, a wide-ranging group of biotech founders and leaders have signed a strongly worded letter opposing the executive order, which temporarily bars entry into the U.S. of citizens from seven majority-Muslim nations. The letter, published online Feb. 7 in Nature Biotechnology, stresses that […]

An Advocacy Rx for Progress in Mental Health

January 31, 2017

Through sustained partnerships between advocacy and industry, the US and Europe can overcome barriers to care. As a source of human suffering, a barrier to workplace productivity, a burden on families and a driver of medical costs, mental illness amounts to an unparalleled public health crisis. Fortunately, there’s an abundance of smart thinking on how to improve the […]

Mental Health: Payer and Advocacy Perspectives in a Time of Policy Uncertainty

January 26, 2017

Heather Gartman discusses patient advocacy in the mental health space, including problem with underfunded research, the numerous stakeholders involved, and ways pharma and these stakeholders can come together to better support this extremely important area of the healthcare ecosystem. Also download our related white paper below, entitled, An Advocacy Rx for Progress in Mental Health.

Impact of 21st Century Cures Act

January 11, 2017

Congress recently passed the 21st Century Cures Act with $4.8 billion dollars in funding and a purpose of speeding the development and approval of new medicines and medical devices the act has generated significant excitement and discussion.  Some of the key components of the legislation include: $4.8 billion dollars additional research funding to NIH over […]

The ACA’s Section 1332 Waivers: Will We See More State Innovation in Health Care Reform?

September 13, 2016

While the Affordable Care Act continues to be politically polarizing, stakeholders from across the health reform landscape are focused on effectively implementing the law and on making incremental – not radical – changes to it. The question is how such change might happen given the deep national divisions about what corrections are needed. One answer […]

The Election’s Impact on Pharma: Preparing for Potential Scenarios

September 13, 2016

The 2016 election will have a major impact on both federal and state healthcare policy. To be sure your organization is prepared for all the possibilities, it’s critical to understand the political dynamics that will be at play under each potential scenario—and what they will mean for the life sciences industry. In a new podcast, […]